EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Study of Ancillary and Novel Morphometric CT and MRI Biomarkers in Stage I-III Fibrosis in Chronic Liver Disease Patients

Barış Can Arslan, Banu Alıcıoğlu

European Journal of Therapeutics · 06.08.2026

DOI: 10.58600/eurjther3062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Therapeutics, online erschienen am 06.08.2026. Verfasst von Barış Can Arslan und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

F1-F3 chronic liver disease is often not recognized by conventional imaging methods; diagnosis and treatment at this stage are crucial in preventing the disease from progressing to the irreversible phase of cirrhosis and its complications. This study aimed to investigate ancillary and novel morphologic imaging findings in the liver using MRI/CT imaging in patients with F1-F3 chronic liver disease.

Methods

Abdominal CT/MR images of 66 patients with histopathological diagnosis of stage I-III fibrosis were retrospectively reviewed. Hemi-diaphragmatic crus thickness, hepato-diaphragmatic fat thickness, periportal fat thickness, gallbladder fossa angle, caudate/right lobe transverse diameter ratio and posterior hepatic notch were evaluated. The clinical and radiological features were compared with those of healthy controls.

Results

Of the F1-F3 chronic liver disease group, 39 (59.1%) were men and 27 (40.9%) were women. Periportal fat thickness, the increased right hemi-diaphragmatic thickness (r-DT Sign), and hilar periportal enlargement were significantly higher in the chronic liver disease group. There was no significant difference between the groups regarding hepato-diaphragmatic fat interposition (HDFI), posterior hepatic notch sign, and gallbladder fossa angle (p > 0.05). Hilar periportal enlargement demonstrated a specificity of 96.7%.

Conclusion

Although the overall sensitivity of routine CT/MRI remains limited for the detection of F1-F3 chronic liver disease, hilar periportal enlargement should be closely monitored as a reliable and specific early finding in the development of chronic liver disease.

Zitieren

APA

Arslan, B. C., & Alıcıoğlu, B. (2026). Study of Ancillary and Novel Morphometric CT and MRI Biomarkers in Stage I-III Fibrosis in Chronic Liver Disease Patients. European Journal of Therapeutics. https://doi.org/10.58600/eurjther3062

Vancouver

Arslan BC, Alıcıoğlu B. Study of Ancillary and Novel Morphometric CT and MRI Biomarkers in Stage I-III Fibrosis in Chronic Liver Disease Patients. European Journal of Therapeutics. 2026. doi:10.58600/eurjther3062

BibTeX
@article{Arslan2026,
  author = {Arslan, Barış Can and Alıcıoğlu, Banu},
  title = {Study of Ancillary and Novel Morphometric CT and MRI Biomarkers in Stage I-III Fibrosis in Chronic Liver Disease Patients},
  journal = {European Journal of Therapeutics},
  year = {2026},
  doi = {10.58600/eurjther3062}
}
Kostenlos starten →